อ้างอิง ของ พิทาวาสแตติน

  1. ↑ Kajinami, K; Takekoshi, N; Saito, Y (2003).
  2. 1 2 3 4 5 Lacy FC, Armstrong LL, Goldman PM, Lance LL, editors. Drug Information Handbook with international trade name index. 18th edition, New Tork, Lexi-Comp®, 2014, p. 585-588, ISBN 978-1-59195-255-8
  3. 1 2 3 4 Dariche Nehdi (July 12, 2012). "The Seventh Statin—Pitavastatin, Part 1: Clinical Studies". Cultu rEbene. สืบค้นเมื่อ December 9, 2015.
  4. ↑ Zydus Cadila launches pitavastatin in India
  5. 1 2 3 4 Mukhtar, R. Y. A.; Reid, J.; Reckless, J. P. D. (2005).
  6. 1 2 3 U.S. Food and Drug Administration (April 4, 2013). "FDA Approves New Cholesterol-Lowering Drug". สืบค้นเมื่อ December 10, 2015.
  7. ↑ "Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia". J Atheroscler Thromb. 16: 654–61. Oct 2009. doi:10.5551/jat.1719. PMID 19907105.
  8. 1 2 3 4 Teramoto, T. (2011). "Pitavastatin: clinical effects from the LIVES Study". Atheroscler Suppl. 12 (3): 285–288.
  9. ↑ Maruyama, T.; Takada, M.; Nishibori, Y.; Fujita, K.; Miki, K.; Masuda, S.; Horimatsu, T.; Hasuike, T. (2011). "Comparison of preventive effect on cardiovascular events with different statins. -The CIRCLE study-". Circ J. 75 (8): 1951–9. doi:10.1038/sj.clpt.6100396. PMID 21673458.
  10. ↑ "Pitavastatin in cardiometabolic disease: therapeutic profile". Cardiovasc Diabetol. 12 Suppl 1: S2. May 30, 2013. doi:10.1186/1475-2840-12-S1-S2. PMID 23819752.
  11. ↑ ScienceDaily (11 May 2013). "Alternative Cholesterol-Lowering Drug for Patients Who Can't Tolerate Statins". ScienceDaily.
  12. ↑ Kawashiri, MA; Nohara, A; Tada, H; Mori, M; Tsuchida, M; Katsuda, S; Inazu, A; Kobayashi, J; Koizumi, J; Mabuchi, H; Yamagishi, M (May 2008). "Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study". Clin Pharmacol Ther. 83 (5): 731–9. doi:10.1038/sj.clpt.6100396. PMID 17957184.
  13. ↑ Ogata, N.; Fujimori, S.; Oka, Y.; Kaneko, K. (2010). "Effects of Three Strong Statins (Atorvastatin, Pitavastatin, and Rosuvastatin) on Serum Uric Acid Levels in Dyslipidemic Patients". Nucleosides, Nucleotides and Nucleic Acids. 29 (4–6): 321. doi:10.1080/15257771003741323.
  14. ↑ PRNewswire (August 17, 2010). "Kowa Announces First EU Marketing Authorisation for Pitavastatin Granted in the UK". PRNewswire.com. สืบค้นเมื่อ December 10, 2015.
  15. ↑ Kowa Pharmaceuticals Europe (November, 2013). "PITAVASTATIN" (PDF). สืบค้นเมื่อ December 9, 2015. Check date values in: |date= (help)

แหล่งที่มา

WikiPedia: พิทาวาสแตติน http://www.chemspider.com/Chemical-Structure.44456... http://www.expresspharmapulse.com/20050303/inthene... http://www.modernmedicine.com/modern-medicine/cont... http://www.sciencedaily.com/releases/2013/03/13031... http://www.kowapharmaceuticals.eu/assets/dl/about_... http://www.accessdata.fda.gov/scripts/cder/drugsat... http://www.fda.gov/NewsEvents/Newsroom/PressAnnoun... //pubmed.ncbi.nlm.nih.gov/17957184 //pubmed.ncbi.nlm.nih.gov/19907105 //pubmed.ncbi.nlm.nih.gov/21673458